Skip to main content

Security report for drug-delivery.org

The Conference Forum · Healthcare · N/a

Medium risk. 7 critical or high findings in Email security, Security headers and 2 other checks.

Security score

64/100

Risk levelMedium

0–100, higher is better. How it is calculated

Drug-delivery.org is a specialized content and event platform serving the drug delivery and formulation ecosystem. It operates under The Conference Forum brand, providing industry professionals with conferences, editorial articles, podcasts, webinars, and marketing services. The website targets pharmaceutical and biotech stakeholders interested in drug delivery innovations and partnerships. The business model focuses on content dissemination and event organization within a niche healthcare sector. The domain is newly registered in 2023, consistent with the business timeline, and hosted on Amazon AWS infrastructure with CloudFront CDN for performance.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching drug-delivery.org

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
20
Email security
60
DNS health
75
Network security
100
GDPR outside view
53
Average
64

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The Conference Forum positions itself as a niche industry media and event organizer with a portfolio of related sites targeting various biotech and clinical research sectors. Its competitive advantage lies in specialized content and curated events that attract professionals in drug delivery and related fields. Revenue streams likely include event sponsorships, advertising, and marketing services. The partnership ecosystem includes several related domains focused on clinical trials, immuno-oncology, and patient engagement. The company appears to be a small but focused player with growth potential in specialized healthcare media.

Security posture

The website employs HTTPS with a valid SSL certificate and uses Google reCAPTCHA v3 to protect forms from abuse. However, DNSSEC is not enabled, and no explicit security headers (e.g., CSP, X-Frame-Options) were detected, which are recommended best practices. No sensitive data exposure or vulnerabilities were found in the HTML content. Privacy compliance is basic, with a privacy policy hosted on the parent domain but no visible cookie consent mechanism. Incident response and security policies are not publicly documented. Overall, the security posture is moderate but could be improved with enhanced DNS security and security headers.

Recommendations

  1. Enable DNSSEC on the domain to improve DNS integrity and security.
  2. Implement standard security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  3. Add a visible cookie consent banner to comply with GDPR and other privacy regulations.
  4. Publish clear security and incident response policies accessible to users.
  5. Provide direct contact information for business and security inquiries to enhance trust.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
The Conference Forum
Description
Serving the Drug Delivery and Formulation Ecosystem with events, editorial content, podcasts, webinars, and marketing services.
Key services
Conferences, Editorial content, Podcasts, Videos/Webcasts, Marketing Services
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Bootstrap 3.4.1, Slick Carousel, Select2, Lightbox, Google reCAPTCHA v3, Google Tag Manager, Microsoft Clarity, LinkedIn Insight Tag, Vimeo Player API
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • HTTPS enabled
  • Google reCAPTCHA v3 implemented
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics, Microsoft Clarity, LinkedIn Insight
Tracking level
moderate
Privacy practices
basic

Advertising

Tracking pixels
LinkedIn Insight, Microsoft Clarity
Marketing tools
Sharer.js, Select2, Slick Carousel
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is a niche industry content and event platform focused on drug delivery and formulation.
  2. Content includes events, editorial articles, podcasts, webinars, and marketing services.
  3. No direct contact emails or phone numbers found on the site; contact likely via parent site.
  4. No explicit privacy or cookie consent banners detected on this site; privacy policy is on parent domain.
  5. Uses modern JavaScript libraries and tracking tools including Google Analytics, Microsoft Clarity, LinkedIn Insight.
  6. No security headers detected in HTML; DNSSEC not enabled.
  7. Domain is new but consistent with business age and content.
  8. No adult or questionable content detected; content is safe and professional.
  9. No visible security or incident response policies published.
Technical notes

Notes

The website uses a modern but standard technology stack including jQuery, Bootstrap 3.4.1, Slick Carousel, Select2, and Lightbox for UI components. It integrates multiple analytics and tracking tools such as Google Analytics, Microsoft Clarity, LinkedIn Insight, and Google Tag Manager. Hosting is via Amazon AWS with CloudFront CDN, supporting moderate performance and good mobile optimization. The site is custom-built or uses a proprietary CMS, with no explicit CMS detected. Accessibility features are basic, and SEO optimization is good with proper meta tags and canonical URLs. Technical risks include lack of DNSSEC and missing security headers, which should be addressed to reduce attack surface.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with drug-delivery.org. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review drug-delivery.org.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.